1. McAuley, Grace E, Yiu, Gloria, Chang, Patrick C, Crooks, Gay M, Kohn, Donald B. 2023. Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing. In Cell, 186, 1398-1416.e23. doi:10.1016/j.cell.2023.02.027. https://pubmed.ncbi.nlm.nih.gov/36944331/
2. Yang, Qian, Feng, Zhijuan, Ding, Danyang, Kang, Chunbo. . CD3D and CD247 are the molecular targets of septic shock. In Medicine, 102, e34295. doi:10.1097/MD.0000000000034295. https://pubmed.ncbi.nlm.nih.gov/37478215/
3. Chen, Zihao, Wang, Maoli, De Wilde, Rudy Leon, Torres-de la Roche, Luz Angela, Shi, Wenjie. 2021. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype. In Frontiers in immunology, 12, 749459. doi:10.3389/fimmu.2021.749459. https://pubmed.ncbi.nlm.nih.gov/34603338/
4. Fortis, Sotirios P, Goulielmaki, Maria, Aubert, Nicolas, Gritzapis, Angelos D, Baxevanis, Constantin N. 2022. Radiotherapy-Related Gene Signature in Prostate Cancer. In Cancers, 14, . doi:10.3390/cancers14205032. https://pubmed.ncbi.nlm.nih.gov/36291815/
5. Lei, Xianghong, Zou, Fangqin, Tang, Xianhu, Cheng, Shengyu, Lei, Xiangxin. . CD3D silencing alleviates diabetic nephropathy via inhibition of JAK/STAT pathway. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 38, e70169. doi:10.1096/fj.202401879R. https://pubmed.ncbi.nlm.nih.gov/39530557/
6. Fischer, Alain, de Saint Basile, Geneviève, Le Deist, Françoise. . CD3 deficiencies. In Current opinion in allergy and clinical immunology, 5, 491-5. doi:. https://pubmed.ncbi.nlm.nih.gov/16264327/
7. Zhu, Zhipeng, Ye, Weipeng, Wu, Xiaofang, Wang, Haibin, Huang, Zhengjie. . Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment. In Bioscience reports, 41, . doi:10.1042/BSR20202898. https://pubmed.ncbi.nlm.nih.gov/33350431/
8. Yang, Yi, Zang, Yiwen, Zheng, Chuang, Chen, Zongyou, Zhou, Yiming. 2020. CD3D is associated with immune checkpoints and predicts favorable clinical outcome in colon cancer. In Immunotherapy, 12, 25-35. doi:10.2217/imt-2019-0145. https://pubmed.ncbi.nlm.nih.gov/31914842/
智鼠故事 
